4-phenyl-3-butenoic acid has been researched along with vorinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, A; Burns, TJ; Matesic, DF | 1 |
| Ali, A; Burns, TJ; Green, GR; Lucrezi, JD; Matesic, DF; May, SW | 1 |
2 other study(ies) available for 4-phenyl-3-butenoic acid and vorinostat
| Article | Year |
|---|---|
Comparative effects of 4-phenyl-3-butenoic acid and vorinostat on cell growth and signaling.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Fatty Acids, Monounsaturated; Hydroxamic Acids; Liver; MAP Kinase Kinase 4; Phosphorylation; Rats; Rats, Inbred F344; Signal Transduction; Vorinostat | 2015 |
Amidation inhibitors 4-phenyl-3-butenoic acid and 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester are novel HDAC inhibitors with anti-tumorigenic properties.
Topics: Animals; Antineoplastic Agents; Caproates; Cell Line; Cell Line, Tumor; Fatty Acids, Monounsaturated; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Models, Molecular; Rats; Vorinostat | 2015 |